These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34853152)

  • 61. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking.
    Wang D; Yao Y; Wang S; Hou Y; Zhao L; Wang H; Chen H; Xu J
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108518
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration.
    Green SA; Liggett SB
    J Biol Chem; 1994 Oct; 269(42):26215-9. PubMed ID: 7929336
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
    Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
    Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
    Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
    Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
    Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors.
    Söhlemann P; Hekman M; Puzicha M; Buchen C; Lohse MJ
    Eur J Biochem; 1995 Sep; 232(2):464-72. PubMed ID: 7556195
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gα
    Wang J; Hanada K; Staus DP; Makara MA; Dahal GR; Chen Q; Ahles A; Engelhardt S; Rockman HA
    Nat Commun; 2017 Nov; 8(1):1706. PubMed ID: 29167435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Location-biased β-arrestin conformations direct GPCR signaling.
    Pham U; Chundi A; Stępniewski TM; Darbha S; Eiger DS; Gazula S; Gardner J; Hicks C; Selent J; Rajagopal S
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of β-arrestin-biased β
    Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
    Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics.
    Li J; Remington JM; Liao C; Parsons RL; Schneebeli S; Braas KM; May V; Brewer M
    J Mol Neurosci; 2022 Jun; 72(6):1358-1373. PubMed ID: 35538393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure-function analysis of β-arrestin Kurtz reveals a critical role of receptor interactions in downregulation of GPCR signaling in vivo.
    Chai F; Xu W; Musoke T; Tarabelsi G; Assaad S; Freedman J; Peterson R; Piotrowska K; Byrnes J; Rogers S; Veraksa A
    Dev Biol; 2019 Nov; 455(2):409-419. PubMed ID: 31325455
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α
    Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
    Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862702
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL; Koehler JA; Yusta B; Drucker DJ
    J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
    [TBL] [Abstract][Full Text] [Related]  

  • 77. GRK2-mediated receptor phosphorylation and Mdm2-mediated β-arrestin2 ubiquitination drive clathrin-mediated endocytosis of G protein-coupled receptors.
    Zhang X; Zheng M; Kim KM
    Biochem Biophys Res Commun; 2020 Dec; 533(3):383-390. PubMed ID: 32962859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Importance of regions outside the cytoplasmic tail of G-protein-coupled receptors for phosphorylation and dephosphorylation.
    Gehret AU; Hinkle PM
    Biochem J; 2010 May; 428(2):235-45. PubMed ID: 20345371
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs.
    Xu TR; Baillie GS; Bhari N; Houslay TM; Pitt AM; Adams DR; Kolch W; Houslay MD; Milligan G
    Biochem J; 2008 Jul; 413(1):51-60. PubMed ID: 18435604
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biased Coupling to β-Arrestin of Two Common Variants of the CB
    Turu G; Soltész-Katona E; Tóth AD; Juhász C; Cserző M; Misák Á; Balla A; Caron MG; Hunyady L
    Front Endocrinol (Lausanne); 2021; 12():714561. PubMed ID: 34484125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.